Clinical Trial Update: Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone [Phase 2]

View source ↗

Summary

This Phase 2 trial in patients aged 65 and older with newly diagnosed multiple myeloma compared two frontline regimens: sequential melphalan/prednisone/Velcade …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED